GLP-1s: A Practical, Lower-Cost Path with Real Medical Support If youve looked into weight-loss medications lately, your feed is probably full of ads for injectable GLP-1s like Wegovy or Zepbound
FDA approval is now being sought for the use of Monjaro for fibrosis, Dr
Its a marathon, so you need others to be on this journey with you
Men's and women's views on penis size across the lifespan
At the higher doses, results were very consistent: All participants lost at least 5% of their body weight Around 3 in 4 lost 15% or more With placebo, only around 1 in 4 lost 5% or more Phase 3 update (TRIUMPH-4, 68 weeks, topline results) In December 2025 , Eli Lilly shared early (topline) results from a larger phase 3 study (TRIUMPH-4)
Global Adoption and Market Growth The use of GLP-1 drugs has surged worldwide, particularly in North America, with significant growth in Europe, the Asia-Pacific, and Latin America